STAT+: FDA promises new AI guidance, and what happened at Epic’s UGM
Reported by STAT News · all stories from statnews.com
Editorial digest
The FDA is preparing to release updated guidance concerning artificial intelligence, alongside notable developments from Epic's recent user group meeting. This covers key areas of digital health innovation and regulation.
Digests are written in our own words from the publisher's headline — we never reproduce article text. Read the original for the full reporting.
Read the full story at STAT News →More like this
Other stories our editors tagged with the same themes.
- Trusted health newsroom10/22/2026
STAT+: Telehealth leapfrogs FDA approval with off-label GLP-1 prescriptions for addiction
Virtual clinics are providing off-label GLP-1 therapies for substance use disorders before receiving formal regulatory authorization.
- Trusted health newsroom9/1/2026
STAT+: FDA clears Stryker’s ‘surgical cockpit’ that uses Apple’s VR headset, Vision Pro
Stryker's system for surgery, using Apple Vision Pro, received FDA clearance.
- Trusted health newsroom10/5/2026
STAT+: Utah plows ahead with more health AI pilots for prescriptions, women’s health
Utah continues expanding health AI pilot programs for prescriptions and women's health.
- Trusted health newsroom9/15/2026
STAT+: Medicare’s AI prior authorization pilot was rushed and full of problems, new documents reveal
Medicare's AI prior authorization program faced issues and was launched too quickly, according to new details.
- Trusted health newsroom10/8/2026
STAT+: AI for breast cancer risk prediction goes DTC, regulatory cloud over Utah sandbox, and AI psychosis
AI for breast cancer risk is now direct-to-consumer; regulatory concerns and AI-induced psychosis are also discussed.
- Trusted health newsroom9/3/2026
STAT+: FDA pilot offers generative AI medical devices a path to patients before they are authorized
FDA pilot program allows generative AI devices to reach patients pre-authorization.